Severe Thrombocytopenia in DLMF/Lymphoma Malignant/ITP: Review and Case report: A New WHO Dengue Fever classification beyond DHF
Abstract
Introduction: Nowadays, incidence of Lymphoma Malignant with mortality is high. Peoples and former health ministry of Indonesia, FS, suspect Wolbachia-Aedes aegypti (DHF), but pediatrician thought to DENV-3/-4 secondary heterogeneity infection in endemic DENV -1/-2 in tropical rainforest area.
Method: Review the pathogenesis of the two Lymphoma Malignant dead cases report, in association with DENV-3 or -4 as secondary heterogeneity infection in tropical rainforest area, Indonesia.
Result: Severity Grade of DHF associated with secondary heterogenous DENV-3 or -4 infections. Conclusion: DENV 1-4 is ss RNA in association with emergency pandemic booster of SARS-CoV-2 which is also ss-RNA virus coated, secondary heterogeneity infection, is in one group with virus which could associated as the caused to Leukemia revealed Immune Thrombocytopenia and other tumor incl. Lymphoma Malignant-non-Hodgkin.
Conclusions: Ss RNA incl. DENV-4 infection as secondary heterogenous DENV-1/-2 or vice versa, which induce anemia and thrombocytopenia ITP with splenomegaly/Lymphoma Malignant, should be classified to DLMF (grade-4) of DHF classification.
Keywords
Download Options
Introduction
Two cases of Acute Lymphoma Malignant mortality in the beginning, and the end of the rainy season in tropical rainforest area (DHF) endemic has shocked peoples in 2024. In Indonesia Aedes aegypti-Wolbachia is spreading in big cities incl. West Jakarta, Surabaya, Semarang and Bali. These two cases are diagnosed in one family. Besides, in the other family, there are also such cases. Number of cases on DENV-3/-4 secondary heterogeneity infection (SHI) 2023 and 2024, and the need of tetravalent DHF vaccine (and no booster COVID-19 AZ due to the recollection from circulation) has been reported in this period, is emphasized not because thrombosis and thrombocytopenia syndrome).
Conclusion
DENV 1-4 is Ss RNA incl. DENV-4 infection as secondary heterogenous DENV-1/-2 or visa versa, which induce anemia and thrombocytopenia ITP with splenomegaly/Lymphoma Malignant, should be classified to DLMF (grade-4) of DHF classification.
Ss RNA incl. DENV-4 infection as secondary heterogenous DENV-1/-2 or vice versa, which induce anemia and thrombocytopenia ITP, then splenomegaly/Lymphoma Malignant, should be classified to DLMF (grade-4) of Dengue Fever classification.